Androgen Deprivation Therapy Market is thriving worldwide by 2026 | Top Key Players like Bayer AG, Johnson & Johnson, Pfizer Inc., Astellas Pharma Inc., Novartis International AG, Veru Inc., Sanofi S.A., GlaxoSmithKline plc

Market Study Report LLC recently added a new title on 2020-2026 Global Androgen Deprivation Therapy Market Report from its database. The report provides study with in-depth overview, describing about the Product, market size, share, Industry Scope and elaborates market outlook and status to 2026.

Androgen deprivation therapy (ADT) is a type of antihormone therapy which is primarily utilized in the cure of prostate cancer. Prostate cancer cells typically requires androgen hormones such as testosterone to grow. The use of androgen deprivation therapy reduces the level of androgen hormones, with surgery or drug delivery to prevent the prostate cells from rising. Various studies have determined that ADT has shown the benefits in patients with metastatic disease, and as an addition to radiation therapy in patients with locally developed disease, including those with adverse intermediate-risk or extreme-risk localized disease.

Request a sample Report of Androgen Deprivation Therapy Market at: https://www.marketstudyreport.com/request-a-sample/2496581/?utm_source=OPR.com/&utm_medium=SP

Surging incidences of prostate cancer, rising male geriatric population, along with increasing government efforts to implement & conduct programs for creating of awareness of screening tests such as Prostate-Specific Antigen (PSA) blood tests are the few factor responsible for high CAGR of the market over the forecast period. For instance, according to the GLOBOCAN 2018 estimates in 2018, about 1,276,106 new cases of prostate cancer were registered worldwide, representing 7.1% of all cancers in men. Similarly, As per the Canadian Cancer Society, it is estimated that 22,900 men will be diagnosed with prostate cancer in 2019 and this represents 20% of all new cancer cases in men in 2019.

Moreover, technological advancement in screening & diagnostic tests is one of the major factor projected to create lucrative growth opportunities to the market growth in the forecasting years. However, side effects associated with ADT is the major factor restraining the growth of global Androgen Deprivation Therapy (ADT) market during the forecast period of 2019-2026.

Major market player included in this report are:
o Pfizer Inc.
o Astellas Pharma Inc.
o Johnson & Johnson
o Novartis International AG
o Veru Inc.
o Sanofi S.A.
o GlaxoSmithKline plc
o Bayer AG
o Orion Corporation
o AstraZeneca Plc.

The regional analysis of global Androgen Deprivation Therapy (ADT) Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the surging investments in R&D for the development of newer immunotherapies and targeted drug therapies to treat prostate cancer in the region.

However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period due to rising awareness among patient towards the treatment of prostate cancer. Further, increasing number of government programs to promote the adoption of ADT, would also create a lucrative opportunity for the growth of the market in the Asia-Pacific region.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Drug Class:
o Antiandrogens
o LHRH Agonists
o LHRH Antagonist
o Others

By Route of Administration:
o Oral
o Injectable

By Distribution Channel:
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies

Table of Contents:

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1. Androgen Deprivation Therapy (ADT) Market, by Drug Class, 2017-2026 (USD Billion)
1.2.2. Androgen Deprivation Therapy (ADT) Market, by Route of Administration, 2017-2026 (USD Billion)
1.2.3. Androgen Deprivation Therapy (ADT) Market, by Distribution Channel, 2017-2026 (USD Billion)
1.2.4. Androgen Deprivation Therapy (ADT) Market, by Region, 2017-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Androgen Deprivation Therapy (ADT) Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Androgen Deprivation Therapy (ADT) Market Dynamics
3.1. Androgen Deprivation Therapy (ADT) Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Androgen Deprivation Therapy (ADT) Market Analysis

Chapter 5. Global Androgen Deprivation Therapy (ADT) Market, by Drug Class

Chapter 6. Global Androgen Deprivation Therapy (ADT) Market, by Route of Administration

Chapter 7. Global Androgen Deprivation Therapy (ADT) Market, by Distribution Channel

Chapter 8. Global Androgen Deprivation Therapy (ADT) Market, Regional Analysis

Chapter 9. Androgen Deprivation Therapy Market Competitive Intelligence

Ask for Discount on Androgen Deprivation Therapy Market Report at: https://www.marketstudyreport.com/check-for-discount/2496581/?utm_source=OPR.com/&utm_medium=SP

Related Reports: https://www.marketwatch.com/press-release/smart-hospitals-market-share-historical-growth-analysis-opportunities-and-forecast-to-2025-2020-04-27

Contact Us:
Market Study Report LLC,
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: www.marketstudyreport.com
Blog: www.marketstudyreport.com/

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

This release was published on openPR.